Law Offices of Thomas J. Lamb

  • About Our Firm
  • Drug Injury
  • Asbestos & Mesothelioma
  • Benzene Diseases
  • Breast Implants
  • Free Case Evaluation
  • FAQs

New Beovu Warnings About Risks Of Retinal Vasculitis And Retinal Vascular Occlusion

June 23, 2020 By Law Offices of Thomas J. Lamb, P.A.

According to the June 9, 2020, FDA Beovu label change approval letter: “This Prior Approval supplemental biologics application provides for the addition of ‘Retinal Vasculitis and/or Retinal Vascular Occlusion’ to the Warnings and Precautions section of the Prescribing Information.”

This Beovu label change comes after postmarketing reports of these Beovu vision-loss side effects such as retinal vasculitis. Several news articles reported the following related points:

  • The Beovu label change is based on a recent internal review conducted by Novartis of adverse events observed in the HAWK & HARRIER clinical trials, including rare postmarketing safety reports of vasculitis.
  • In connection with its Beovu label change, Novartis stated that a review of these postmarketing events concluded that “there is a confirmed safety signal of rare adverse events termed as ‘retinal vasculitis’ and/or ‘retinal vascular occlusion’ that may result in severe vision loss.”

As background, the FDA approved Beovu for the treatment of wet AMD on October 8, 2019.

We are currently investigating drug injury lawsuits against Novartis for Beovu causing vision loss and blindness due to retinal vasculitis, retinal vascular occlusion, and intraocular inflammation.

[View article at original source]

Beovu

Free Case Evaluation

Strictly Confidential, No Obligation

Filed Under: Unsafe Drugs Tagged With: Beovu, retinal vasculitis

Find What You Want Here

Get Free Case Evaluation

We encourage you to submit an online Case Evaluation Form form – it is confidential and there is no obligation.

Or call our toll-free number, 800-426-9535, to speak directly to attorney Tom Lamb about your possible case.

Feel Free To Contact Us

Quick Contact Form
 
Send an Email to Tom Lamb

(800) 426-9535

Main Navigation Menu

  • Drug Injury Cases
  • Asbestos-Mesothelioma Cases
  • Benzene Disease Claims
  • GenX Cancer Cases
  • Breast Implant Cases
  • Case Evaluation Menu
  • Quick Contact Form
  • About Our Firm
  • Frequently Asked Questions
  • Medical Records Charges
  • Collection of Articles
  • Sitemap

Lamb Law Office Newsletter

Lamb Law Office Newsletter provides periodic updates about some of the cases that we are working on for clients, as well as an information resource you might find helpful.

Subscribe using Form below.

Subscription Form

* indicates required

Our Other Websites

Drug Injury Law
Drug Injury Watch
Drug Safety Developments
Asbestos & Mesothelioma

Contact Information

Law Offices of Thomas J. Lamb, P.A.
1908 Eastwood Road, Suite 225
Wilmington, North Carolina 28403
910-256-2971 | 800-426-9535
TJL@LambLawOffice.com

  • Home
  • Frequently Asked Questions
  • Disclaimer and Copyright Notices

Copyright © 2021 · Law Offices of Thomas J. Lamb, P.A.